Search

everythinglearnresearchcommunity

for

Search:↓

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Finasteride effectively treats hair loss in men with minimal side effects.

Non-obese women with hair loss have higher heart disease risk.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Semecarpus anacardium Linn. is a plant with many health benefits, including reducing inflammation, fighting cancer, and stimulating hair growth.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

New regenerative therapies show promise for treating hair loss.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Overweight women with PCOS are more likely to have excess male hormones.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.